Jones Financial Companies Lllp cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 59.7% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 27,228 shares of the healthcare conglomerate's stock after selling 40,358 shares during the quarter. Jones Financial Companies Lllp's holdings in UnitedHealth Group were worth $13,266,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in UNH. Rise Advisors LLC raised its stake in UnitedHealth Group by 14.1% in the first quarter. Rise Advisors LLC now owns 728 shares of the healthcare conglomerate's stock worth $381,000 after buying an additional 90 shares in the last quarter. Panoramic Capital LLC bought a new position in shares of UnitedHealth Group in the 1st quarter worth about $4,190,000. Parkman Healthcare Partners LLC grew its holdings in UnitedHealth Group by 151.1% in the first quarter. Parkman Healthcare Partners LLC now owns 50,213 shares of the healthcare conglomerate's stock worth $26,299,000 after purchasing an additional 30,213 shares during the period. Permanens Capital L.P. boosted its position in shares of UnitedHealth Group by 68.0% in the 1st quarter. Permanens Capital L.P. now owns 2,493 shares of the healthcare conglomerate's stock worth $1,306,000 after purchasing an additional 1,009 shares in the last quarter. Finally, Petrus Trust Company LTA raised its stake in UnitedHealth Group by 0.6% during the first quarter. Petrus Trust Company LTA now owns 119,179 shares of the healthcare conglomerate's stock valued at $62,420,000 after buying an additional 679 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.
Analyst Upgrades and Downgrades
A number of brokerages recently issued reports on UNH. Hsbc Global Res cut shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. Wolfe Research cut their price target on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a report on Tuesday, May 20th. Wall Street Zen cut UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Bank of America lifted their target price on UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a report on Monday, August 18th. Finally, Raymond James Financial downgraded UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday, May 14th. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and a consensus target price of $354.86.
Read Our Latest Research Report on UnitedHealth Group
UnitedHealth Group Stock Up 1.6%
Shares of UNH stock opened at $320.46 on Tuesday. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company has a 50 day simple moving average of $288.96 and a two-hundred day simple moving average of $371.54. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a market cap of $290.24 billion, a P/E ratio of 13.88, a P/E/G ratio of 2.04 and a beta of 0.45.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business's quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be paid a $2.21 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.8%. UnitedHealth Group's dividend payout ratio is 38.30%.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.